To evaluate the effect of arjakadi vati in premature ejaculation

A single blind randomized placebo controlled clinical study to evaluate the effect of arjakadi vati in shukraghata vata with special reference to premature ejacualtion

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053509

Enrollment

Registered

2023-06-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N531- Ejaculatory dysfunction

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. ejaculation prior to ten penile thrusts. 2. ejaculation before on or within one minute of the sexual act after penetration 3. unable to satisfy partner in at least 50% the coital incidences 4. unable to delay ejaculation till person wishes

Exclusion criteria

Exclusion criteria: 1. the factor that affect the duration of Excitement phase of sexual act such as novelity of the partner or situation and the recent frequency of sexual act is taken into account. 2. persons having very short post ejaculatory refractory period 3. major psychiatric illness 4. subject with HTN and Uncontrolled DM 5. Structural Deformity like Cryptorchidism, Varicocele, Hydrocele,etc.

Design outcomes

Primary

Measure	Time frame
Improvement in Intravaginal Ejaculatory Latency TimeTimepoint: 0th Day, 45th Day and 93rd Day	—

Secondary

Measure	Time frame
Improvement in other cardinal features of premature ejaculation (sexual desire, performance anxiety ,control over ejaculation, patient satisfaction.Timepoint: 0th day,45th day, and 93rd day	—

Countries

India

Contacts

Public ContactDr Muttu Mantesh hadapad

Shri DGM Ayurvedic Medical College PG PHD Studies and Research Center, Shivanand math road, Gadag

shettar_dr@yahoo.co.in9845613116

Outcome results